World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Watson to Buy Actavis in $5.92 Billion Deal
Keywords:
Tags: Pharmaceutical,
Watson Pharmaceutical's acquisition of Swiss company Actavis in a 4.5 billion euros deal makes it the third largest generics manufacturer after Teva of Israel and Novartis AG's Sandoz unit. Actavis was owned by Icelandic billionaire Thor Bjorgolfsson's private equity firm and was taken over by Deusche Bank when the Icelandic bank Landsbanki Islands collapsed in 2008, leading to restructuring of debt.
Watson Pharmaceuticals
03/22/2012
Grouped Articles
Watson Nears $5.9 Billion Actavis Deal
Wall Street Journal 03/22/2012
Watson to Buy Actavis in $5.92 Billion Deal
Wall Street Journal 04/24/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
